Article Fact Checked

Medically Reviewed

/ Updated December 29th, 2020

New Drug Combo Approved for Hard-to-Treat Diffuse Large B-Cell Lymphoma

NOW
PLAYING
May is Bladder Cancer Awareness Month
NOW
PLAYING
CAR T-Cell Therapy's Current and Future Success
NOW
PLAYING
All About Acute Lymphoblastic Leukemia
NOW
PLAYING
Should Cancer Patients Receive Full Body Scans Before Being Declared In Remission? A Warrior's Final Wish
NOW
PLAYING
Some Hand Sanitizers Found to Contain Cancer-Causing Compound Benzene; How Cancer Patients Can Protect Themselves During COVID-19
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.